Robert W. Baird Cuts agilon health (NYSE:AGL) Price Target to $5.00

agilon health (NYSE:AGL - Get Free Report) had its target price dropped by research analysts at Robert W. Baird from $6.00 to $5.00 in a report released on Tuesday,Benzinga reports. The firm currently has a "neutral" rating on the stock. Robert W. Baird's price target indicates a potential upside of 24.25% from the company's current price.

A number of other equities research analysts have also weighed in on the stock. Needham & Company LLC reiterated a "hold" rating on shares of agilon health in a report on Friday, March 21st. Royal Bank of Canada upped their price objective on agilon health from $3.00 to $3.50 and gave the stock an "outperform" rating in a research note on Wednesday, February 26th. Macquarie assumed coverage on shares of agilon health in a report on Monday, December 16th. They issued a "neutral" rating and a $3.00 target price for the company. Citigroup raised shares of agilon health from a "sell" rating to a "neutral" rating and lifted their price objective for the stock from $1.75 to $2.25 in a research report on Friday, January 10th. Finally, Sanford C. Bernstein upgraded shares of agilon health from a "market perform" rating to an "outperform" rating and raised their target price for the company from $3.30 to $8.50 in a research note on Tuesday, April 8th. Two research analysts have rated the stock with a sell rating, thirteen have given a hold rating and three have issued a buy rating to the company. According to MarketBeat, the company presently has a consensus rating of "Hold" and a consensus target price of $4.60.

agilon health Trading Down 26.4 %

AGL stock traded down $1.45 during midday trading on Tuesday, reaching $4.02. 22,402,423 shares of the company traded hands, compared to its average volume of 4,792,850. The business has a 50 day moving average of $4.14 and a 200-day moving average of $3.12. agilon health has a 52-week low of $1.50 and a 52-week high of $7.73. The company has a debt-to-equity ratio of 0.06, a quick ratio of 1.29 and a current ratio of 1.29. The firm has a market capitalization of $1.66 billion, a price-to-earnings ratio of -4.28 and a beta of 0.38.

Institutional Trading of agilon health

Institutional investors and hedge funds have recently made changes to their positions in the business. Captrust Financial Advisors boosted its stake in agilon health by 10.9% during the 4th quarter. Captrust Financial Advisors now owns 35,485 shares of the company's stock worth $67,000 after purchasing an additional 3,494 shares during the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. boosted its holdings in agilon health by 2.5% in the fourth quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 206,991 shares of the company's stock valued at $393,000 after purchasing an additional 5,107 shares during the period. MetLife Investment Management LLC raised its holdings in shares of agilon health by 4.0% in the 4th quarter. MetLife Investment Management LLC now owns 174,551 shares of the company's stock valued at $332,000 after purchasing an additional 6,762 shares in the last quarter. Symphony Financial Services Inc. lifted its stake in agilon health by 44.3% during the fourth quarter. Symphony Financial Services Inc. now owns 23,000 shares of the company's stock worth $44,000 after purchasing an additional 7,058 shares during the last quarter. Finally, Signaturefd LLC boosted its holdings in agilon health by 143.0% in the fourth quarter. Signaturefd LLC now owns 14,388 shares of the company's stock valued at $27,000 after purchasing an additional 8,467 shares in the last quarter.

agilon health Company Profile

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.